惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

月光博客
月光博客
Martin Fowler
Martin Fowler
博客园_首页
量子位
T
Tailwind CSS Blog
博客园 - Franky
G
Google Developers Blog
D
DataBreaches.Net
Vercel News
Vercel News
B
Blog
Recent Announcements
Recent Announcements
S
SegmentFault 最新的问题
M
MIT News - Artificial intelligence
爱范儿
爱范儿
博客园 - 【当耐特】
The Cloudflare Blog
H
Help Net Security
云风的 BLOG
云风的 BLOG
P
Proofpoint News Feed
C
Check Point Blog
有赞技术团队
有赞技术团队
Microsoft Security Blog
Microsoft Security Blog
酷 壳 – CoolShell
酷 壳 – CoolShell
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Merck & Co., Inc. (MRK) Q1 2026 Earnings Call Transcript
2026-05-01 · via All Articles on Seeking Alpha

Q1: 2026-04-30 Earnings Summary

EPS of -$1.28 beats by $0.19

 | 

Revenue of

$16.29B

(4.87% Y/Y)

beats by $439.67M

Merck & Co., Inc. (MRK) Q1 2026 Earnings Call April 30, 2026 9:00 AM EDT

Company Participants

Peter Dannenbaum - Vice President of Investor Relations
Robert Davis - Chairman, President & CEO
Caroline Litchfield - Executive VP & CFO
Dean Li - Executive VP & President of Merck Research Laboratories

Conference Call Participants

Carter Gould - Cantor Fitzgerald & Co., Research Division
Jason Gerberry - BofA Securities, Research Division
Michael Yee - UBS Investment Bank, Research Division
Asad Haider - Goldman Sachs Group, Inc., Research Division
Vamil Divan - Guggenheim Securities, LLC, Research Division
Daina Graybosch - Leerink Partners LLC, Research Division
Steve Scala - TD Cowen, Research Division
Christopher Schott - JPMorgan Chase & Co, Research Division
Louise Chen - Scotiabank Global Banking and Markets, Research Division
Umer Raffat - Evercore ISI Institutional Equities, Research Division
James Shin - Deutsche Bank AG, Research Division
Geoffrey Meacham - Citigroup Inc., Research Division

Presentation

Operator

Thank you for standing by. Welcome to the Merck & Co., Inc., Rahway, New Jersey, USA, First Quarter Sales and Earnings Conference Call. [Operator Instructions] This call is being recorded. If you have any objections, you may disconnect at this time.

I would now like to turn the call over to Mr. Peter Dannenbaum, Senior Vice President, Investor Relations. Sir, you may begin.

Peter Dannenbaum
Vice President of Investor Relations

Thank you, Julie, and good morning, everyone. Welcome to the First Quarter 2026 Conference Call for Merck & Co., Inc., Rahway, New Jersey, USA. Speaking on today's call will be Rob Davis, Chairman and Chief Executive Officer; Caroline Litchfield, Chief Financial Officer; and Dr. Dean Li, President of Research Labs.

Before we get started, I'd like to point out that we have items in our GAAP results such as acquisition-related charges, restructuring costs and certain other items that we have excluded from our non-GAAP results. There is a reconciliation in our